Literature DB >> 26350399

Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin.

Kelly L Williams1, Emily P McCann1, Jennifer A Fifita1, Katharine Zhang1, Emma L Duncan2, Paul J Leo3, Mhairi Marshall3, Dominic B Rowe1, Garth A Nicholson4, Ian P Blair5.   

Abstract

Missense and frameshift mutations in TRAF family member-associated NF-kappa-B activator (TANK)-binding kinase 1 (TBK1) have been reported in European sporadic and familial amyotrophic lateral sclerosis (ALS) cohorts. To assess the role of TBK1 in ALS patient cohorts of wider ancestry, we have analyzed whole-exome sequence data from an Australian cohort of familial ALS (FALS) patients and controls. We identified a novel TBK1 deletion (c.1197delC) in a FALS patient of Chinese origin. This frameshift mutation (p.L399fs) likely results in a truncated protein that lacks functional domains required for adapter protein binding, as well as protein activation and structural integrity. No novel or reported TBK1 mutations were identified in FALS patients of European ancestry. This is the first report of a TBK1 mutation in an ALS patient of Asian origin and indicates that sequence variations in TBK1 are a rare cause of FALS in Australia.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Frameshift; Gene; Motor neuron disease; Mutation; TBK1

Mesh:

Substances:

Year:  2015        PMID: 26350399     DOI: 10.1016/j.neurobiolaging.2015.08.013

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  12 in total

Review 1.  Autophagy Dysfunction in ALS: from Transport to Protein Degradation.

Authors:  Marta Cozzi; Veronica Ferrari
Journal:  J Mol Neurosci       Date:  2022-06-16       Impact factor: 2.866

Review 2.  ALS: Recent Developments from Genetics Studies.

Authors:  Martine Therrien; Patrick A Dion; Guy A Rouleau
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

3.  TBK1 interacts with tau and enhances neurodegeneration in tauopathy.

Authors:  Measho H Abreha; Shamsideen Ojelade; Eric B Dammer; Zachary T McEachin; Duc M Duong; Marla Gearing; Gary J Bassell; James J Lah; Allan I Levey; Joshua M Shulman; Nicholas T Seyfried
Journal:  J Biol Chem       Date:  2021-05-07       Impact factor: 5.157

Review 4.  TBK1: a new player in ALS linking autophagy and neuroinflammation.

Authors:  James A Oakes; Maria C Davies; Mark O Collins
Journal:  Mol Brain       Date:  2017-02-02       Impact factor: 4.041

5.  TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.

Authors:  Julie van der Zee; Ilse Gijselinck; Sara Van Mossevelde; Federica Perrone; Lubina Dillen; Bavo Heeman; Veerle Bäumer; Sebastiaan Engelborghs; Jan De Bleecker; Jonathan Baets; Ellen Gelpi; Ricardo Rojas-García; Jordi Clarimón; Alberto Lleó; Janine Diehl-Schmid; Panagiotis Alexopoulos; Robert Perneczky; Matthis Synofzik; Jennifer Just; Ludger Schöls; Caroline Graff; Håkan Thonberg; Barbara Borroni; Alessandro Padovani; Albena Jordanova; Stayko Sarafov; Ivailo Tournev; Alexandre de Mendonça; Gabriel Miltenberger-Miltényi; Frederico Simões do Couto; Alfredo Ramirez; Frank Jessen; Michael T Heneka; Estrella Gómez-Tortosa; Adrian Danek; Patrick Cras; Rik Vandenberghe; Peter De Jonghe; Peter P De Deyn; Kristel Sleegers; Marc Cruts; Christine Van Broeckhoven; Johan Goeman; Dirk Nuytten; Katrien Smets; Wim Robberecht; Philip Van Damme; Jan De Bleecker; Patrick Santens; Bart Dermaut; Jan Versijpt; Alex Michotte; Adrian Ivanoiu; Olivier Deryck; Bruno Bergmans; Jean Delbeck; Marc Bruyland; Christiana Willems; Eric Salmon; Pau Pastor; Sara Ortega-Cubero; Luisa Benussi; Roberta Ghidoni; Giuliano Binetti; Isabel Hernández; Mercè Boada; Agustín Ruiz; Sandro Sorbi; Benedetta Nacmias; Silvia Bagnoli; Sandro Sorbi; Raquel Sanchez-Valle; Albert Llado; Isabel Santana; Maria Rosário Almeida; Giovanni B Frisoni; Walter Maetzler; Radoslav Matej; Matthew J Fraidakis; Gabor G Kovacs; Gian Maria Fabrizi; Silvia Testi
Journal:  Hum Mutat       Date:  2017-01-19       Impact factor: 4.878

Review 6.  What causes amyotrophic lateral sclerosis?

Authors:  Sarah Martin; Ahmad Al Khleifat; Ammar Al-Chalabi
Journal:  F1000Res       Date:  2017-03-28

7.  Genetic epidemiology of motor neuron disease-associated variants in the Scottish population.

Authors:  Holly A Black; Danielle J Leighton; Elaine M Cleary; Elaine Rose; Laura Stephenson; Shuna Colville; David Ross; Jon Warner; Mary Porteous; George H Gorrie; Robert Swingler; David Goldstein; Matthew B Harms; Peter Connick; Suvankar Pal; Timothy J Aitman; Siddharthan Chandran
Journal:  Neurobiol Aging       Date:  2016-12-21       Impact factor: 4.673

8.  Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival.

Authors:  Qian-Qian Wei; Yongping Chen; Bei Cao; Ru Wei Ou; Lingyu Zhang; Yanbing Hou; Xiang Gao; Huifang Shang
Journal:  Mol Neurodegener       Date:  2017-09-21       Impact factor: 14.195

Review 9.  Role of Optineurin in the Mitochondrial Dysfunction: Potential Implications in Neurodegenerative Diseases and Cancer.

Authors:  Robert Weil; Emmanuel Laplantine; Shannel Curic; Pierre Génin
Journal:  Front Immunol       Date:  2018-06-19       Impact factor: 7.561

Review 10.  Human TBK1: A Gatekeeper of Neuroinflammation.

Authors:  Liyana Ahmad; Shen-Ying Zhang; Jean-Laurent Casanova; Vanessa Sancho-Shimizu
Journal:  Trends Mol Med       Date:  2016-06       Impact factor: 15.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.